OKYO Pharma (OKYO) Debt Ratio (2023 - 2025)
OKYO Pharma (OKYO) posted quarterly Debt Ratio of 0.04 for Q3 2025, up 6159.93% year-over-year from 0.0 in Q3 2024, and down 82.88% quarter-over-quarter from 0.23 in Q1 2025.
OKYO Pharma (OKYO) Debt Ratio (2023 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has reported Debt Ratio for 3 consecutive years, with 0.04 the latest figure, recorded in Q3 2025.
- In Q3 2025, Debt Ratio rose 6159.93% year-over-year to 0.04; the TTM figure through Sep 2025 stood at 0.04 (up 6159.93% YoY), while the FY2025 annual figure was 0.23, changed 0.41% from the prior year.
- Debt Ratio slipped to 0.04 in Q3 2025 per OKYO's latest filing, from 0.23 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.23 in Q1 2025 and bottomed at 0.0 in Q3 2024.
- Historically, Debt Ratio has averaged 0.15 across 3 years, with a median of 0.22 in 2023.
- Annual changes were most pronounced in 2024 — Debt Ratio plunged 99.71% — and 2025, when it surged 6159.93%.
- OKYO Pharma's Debt Ratio stood at 0.22 in 2023, then slumped by 99.71% to 0.0 in 2024, then surged by 6159.93% to 0.04 in 2025.
- Business Quant data shows OKYO's Debt Ratio at 0.04 in Q3 2025, 0.23 in Q1 2025, and 0.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | OKYO Pharma | 1.47 Bn | 1.47 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.23 |
| Sep 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.23 |
| Sep 30, 2023 | 0.22 |